Prescription Drugs Overview
- Prescription drugs provide relief from various health issues.
- Half of Americans took at least one prescription drug monthly; over 13% took five or more.
- Prescription drug consumption is increasing:
- 2020: 6. 4 billion prescriptions filled in the U. S.
- 2023: Over 210 billion daily doses consumed annually.
- A child born in 2019 is expected to spend half of their life on prescription medications.
Pharmaceutical Industry Insights
- The U. S. is the largest consumer of prescription drugs globally.
- The country spends nearly twice as much on prescriptions as all other nations combined.
- In 2023, global pharmaceutical sales were estimated at $1. 6 trillion.
- The top ten U. S. pharmaceutical companies are worth over $2. 1 trillion.
New Medication Development
- Growth driven by new medications like biologics and peptides.
- Biologics are derived from living sources; costs can be high (e. g. , Humira cost about $66,000).
- FDA approved 17 biologics in 2023, a significant increase from previous years.
- Americans consumed 72% of top 50 biologic drugs in 2022.
- Peptides, such as GLP-1 medications, are growing in popularity.
Costs and Market Trends
- Medicare Part D paid over $22 billion for GLP-1 medications in 2023, up 130% in two years.
- U. S. drug prices are more than double those in other countries; brand-name drugs are four times more expensive.
Political Spending by Pharmaceutical Companies
- Pharmaceutical companies earned $387 billion from Medicare Part D and Medicaid in 2023.
- Significant campaign contributions made during presidential and mid-term elections.
- Industry spent over $150 million on lobbying in 2024, with a high proportion of lobbyists being former government employees.
- The pharmaceutical lobby outspent other industries in the last 25 years.
Research and Development Costs
- Developing a new medication can cost up to $2 billion.
- Congress supported research through specific legislation, allowing continued full-price charging for rare disease drugs.
- The pharmaceutical industry spent $83 billion on R&D in 2019, increasing to nearly double by 2023.
- NIH spent over $360 billion on disease research from 2014 to 2023.
Vaccines Market
- Over 7 billion vaccine doses delivered in 2023; market valued at about $77 billion.
- Increased vaccination recommendations: from 7 diseases in the 1980s to 17 illnesses today.
- Vaccination costs can range from $3,500 to over $5,000.
- CDC provided vaccines to about 117 million low-income children, preventing millions of illnesses and saving significant costs.
- Federal government purchased 1. 2 billion COVID-19 doses at a cost of $25. 3 billion.
No comments:
Post a Comment